Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
25th week of 2020 patent applcation highlights part 10
Patent application number
Title
Published
20200188308
SYSTEMS AND METHODS FOR AUTOMATED PELLET PRESSING AND VIALING
2020-06-18
20200188309
DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME
2020-06-18
20200188310
STABLE CAPSULES WITH FECAL MICROBIOTA OR A CULTURE OF MICROORGANISMS
2020-06-18
20200188311
EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISEASE
2020-06-18
20200188312
COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A SPECIFIC HYDROXYALKYL METHYLCELLULOSE
2020-06-18
20200188313
LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
2020-06-18
20200188314
GEL FORMULATION FOR TREATING DIABETIC FOOT ULCER INFECTIONS
2020-06-18
20200188315
Nanoparticles Containing a Taxane and Their Use
2020-06-18
20200188316
TRANSDERMAL FORMULATIONS SUITABLE FOR ADMINISTRATION OF NATURAL PRODUCTS COMPRISING PLANT FLOUR AND AN ADHESIVE
2020-06-18
20200188317
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE
2020-06-18
20200188318
COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES
2020-06-18
20200188319
Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease
2020-06-18
20200188320
Geranium oil and constituents thereof for treatment of neurodegenerative diseases
2020-06-18
20200188321
METHODS OF ADMINISTERING ANIONIC CANNABINOID MOLECULES DISSOLVED IN WATER
2020-06-18
20200188322
USE OF CANNABIDIOL IN TREATMENT OF PULMONARY HYPERTENSION
2020-06-18
20200188323
Composition With Enhanced Passenger Molecule Loading
2020-06-18
20200188324
TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL
2020-06-18
20200188325
COSMETIC AND TOPICAL COMPOSITIONS COMPRISING CANNABIGEROL
2020-06-18
20200188326
COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES
2020-06-18
20200188327
FORMULATIONS FOR EXTENDING LIFESPAN AND HEALTHSPAN
2020-06-18
20200188328
SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS
2020-06-18
20200188329
COMPOSITION FOR INHIBITING GROWTH OF BREAST CANCER STEM CELLS CONTAINING PHENYLACETALDEHYDE
2020-06-18
20200188330
Nutraceutical Compositions Comprising C60 and Curcumin
2020-06-18
20200188331
Nutraceutical Compositions Comprising C60 and Cox-2 Inhibitor
2020-06-18
20200188332
METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY
2020-06-18
20200188333
ABUSE-PROOFED DOSAGE FORM
2020-06-18
20200188335
Metabolic Markers of Attention Deficit Hyperactivity Disorder
2020-06-18
20200188336
PHARMACOLOGY OF VISUAL CYCLE MODULATORS
2020-06-18
20200188337
Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
2020-06-18
20200188338
ANESTHETIC AGENT MICRO AND NANO PARTICLES, AND METHODS OF MAKING AND USING THE SAME
2020-06-18
20200188339
Nutraceutical Composition Comprising C60 And Ketone Esters
2020-06-18
20200188340
Methods of Treating Hair Related Conditions
2020-06-18
20200188341
Controlled Release Dosage Form
2020-06-18
20200188342
SUSTAINED RELEASE SUSPENSION CONTAINING DEZOCINE ANALOGUE ESTER AND PREPARATION METHOD THEREFOR
2020-06-18
20200188343
COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
2020-06-18
20200188344
COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
2020-06-18
20200188345
ARTICLES OF MANUFACTURE AND METHODS OF TREATMENT FOR ANEMIA
2020-06-18
20200188346
METHOD OF TREATMENT
2020-06-18
20200188347
ADMINISTRATION METHOD FOR FORMULATED CANNABINOID COMPOSITIONS
2020-06-18
20200188348
Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders
2020-06-18
20200188349
MDI RELATED PRODUCTS AND METHODS OF USE
2020-06-18
20200188350
BIOACTIVE MOLECULES FROM OROXYLUM INDICUM AND THEIR THERAPEUTIC APPLICATIONS
2020-06-18
20200188351
TOPICAL HAIR AND SKIN FORMULATION
2020-06-18
20200188352
ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
2020-06-18
20200188353
Pharmaceutical Composition for Prevention or Treatment of Bone-Related Disease
2020-06-18
20200188354
ANTIFUNGAL PEPTOIDS
2020-06-18
20200188355
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 8 (TRPM8) ANTAGONISTS AND METHODS OF USE
2020-06-18
20200188356
Novel Circular RNA Biomarkers for Heart Failure
2020-06-18
20200188357
SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
2020-06-18
20200188358
METHODS FOR THE TREATMENT OF DEPRESSION
2020-06-18
20200188359
ALKALOIDS FROM SPONGE, SCAFFOLDS FOR THE INHIBITIION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)
2020-06-18
20200188360
METHODS AND COMPOSITIONS FOR TREATING HYPERHIDROSIS
2020-06-18
20200188361
USE OF MITOCHONDRIAL ACTIVITY INHIBITORS FOR THE TREATMENT OF POOR PROGNOSIS ACUTE MYELOID LEUKEMIA
2020-06-18
20200188362
METHODS FOR TREATING EPILEPSY
2020-06-18
20200188363
THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED IRINOTECAN AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
2020-06-18
20200188364
ANTIFUNGAL COMPOUNDS
2020-06-18
20200188365
USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER
2020-06-18
20200188366
HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY
2020-06-18
20200188367
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
2020-06-18
20200188368
NOVEL TRIPLE COMBINATION FORMULATIONS FOR ANTIEMETIC THERAPY
2020-06-18
20200188369
METHODS FOR THE TREATMENT OF MYOPIA
2020-06-18
20200188370
ALK5 INHIBITORS
2020-06-18
20200188371
METHODS FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY
2020-06-18
20200188372
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
2020-06-18
20200188373
COMPOSITIONS AND METHODS FOR TREATING CANCER
2020-06-18
20200188374
SUSTAINED-RELEASE ANESTHETIC COMPOSITIONS AND METHODS OF PREPARATION THEREOF
2020-06-18
20200188375
Methods Of Treating Fabry Patients Having Renal Impairment
2020-06-18
20200188376
ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
2020-06-18
20200188377
DRUG CONTAINING PYRIDYLAMINOACETIC ACID COMPOUND
2020-06-18
20200188378
Methylphenidate Extended Release Chewable Tablet
2020-06-18
20200188379
USE OF A GLUTARIMIDE DERIVATIVE TO TREAT DISEASES RELATED TO THE ABERRANT ACTIVITY OF CYTOKINES
2020-06-18
20200188380
PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB MESYLATE
2020-06-18
20200188381
USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR ACTIVATING IMMUNE RESPONSES
2020-06-18
20200188382
PHARMACEUTICAL COMPOSITION FOR INDUCING PROGRAMMED CELL DEATH IN CANCER CELLS
2020-06-18
20200188383
METHODS FOR SOLID TUMOR TREATMENT
2020-06-18
20200188384
METHODS FOR SOLID TUMOR TREATMENT
2020-06-18
20200188385
CRENOLANIB COMBINATION THERAPY
2020-06-18
20200188386
THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED DOCETAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
2020-06-18
20200188387
SOLID FORMS OF BERBERINE URSODEOXYCHOLATE AND COMPOSITIONS AND METHODS THEREOF
2020-06-18
20200188388
METHODS AND COMPOSITIONS FOR POTENTIATING CNS DRUGS AND REDUCING THEIR SIDE EFFECTS
2020-06-18
20200188389
COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION
2020-06-18
20200188390
ORAL SUSPENSION OF TEMOZOLOMIDE
2020-06-18
20200188391
BIOEQUIVALENT PHARMACEUTICAL COMPOSITION OF VORTIOXETINE HYDROBROMIDE
2020-06-18
20200188392
TREATMENT OF EPILEPSY WITH PLINABULIN OR HALIMADE OR DIKETOPIPERAZINE DERIVATIVES
2020-06-18
20200188393
PHARMACEUTICAL FORMLATIONS
2020-06-18
20200188394
TREATMENT OF LIVER DISEASE
2020-06-18
20200188395
COMPOSITION AND METHODS FOR PREVENTING OR REDUCING THE INCIDENCE OF TRANSIENT ISCHEMIC ATTACKS
2020-06-18
20200188396
METHOD AND COMPOSITION RELATED TO COMBINATION THERAPY FOR ADDICTION
2020-06-18
20200188397
BIHETEROARYL COMPOUNDS AND USES THEREOF
2020-06-18
20200188398
METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
2020-06-18
20200188399
METHOD FOR TREATING INTERSTITIAL LUNG DISEASE
2020-06-18
20200188400
KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
2020-06-18
20200188401
TREATMENT OF HER2 POSITIVE CANCERS
2020-06-18
20200188402
COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA
2020-06-18
20200188403
TREATMENT OF ORGANOPHOSPHATE EXPOSURE WITH OCINAPLON
2020-06-18
20200188404
METHODS OF TREATING AND INHIBITING EBOLA VIRUS INFECTION
2020-06-18
20200188405
COMPOSITION FOR TREATING OCULAR DISORDERS SUCH AS MACULAR DEGENERATION, RETINOPATHY AND GLAUCOMA
2020-06-18
20200188406
LIQUID FORMULATIONS OF FOSAPREPITANT
2020-06-18
20200188407
COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS
2020-06-18
20200188408
SMALL-MOLECULE POVIDONE ANALOGS IN COAMORPHOUS PHARMACEUTICAL PHASES
2020-06-18